@VIMAL_AGRAWAL @Meetkatrodiya @Ashar_Mann
The order book is ~ 325 Cr.
Let say FY Revenue comes out 170 Cr.
How much order they would be left with at start of FY25 ?

I’ve started tracking recently but before i make a move CMP doubled just in a 1 month from 144.

I find tarachand to be good name with bright prospects for few more years.but Before i give into FOMO. I wish to study & understand what could be prudent approach to hook up with ? . Let it migrate to mainboard or wait for a blimp ? What could be Base/Bear case scenario ?

Market cap is ~400 Cr.PE~34, CMP ~ 5.03 times book value

Jubilant Ingrevia has recently inaugurated an innovative facility for Diketene Derivatives in Gajraula, Uttar Pradesh. This plant will significantly enhance the company’s production capacity by adding 2,000 tonnes per annum (tpa) for manufacturing high-value esters.

The expansion into diketene derivatives represents a strategic move by the company to tap into new markets, particularly in the US and EU regions. These derivatives are poised for substantial growth, positioning them as a key segment within the company’s specialty chemicals portfolio.

With this facility,the organisation is not only bolstering its existing offerings but also signalling a shift in strategy towards capturing emerging opportunities in downstream derivatives. The company is committed to further strengthening its presence in this segment, with plans to introduce new derivatives in addition to the existing ones.

This forward-looking approach aligns with the corporation’s long-term strategic objectives, as it aims to build an advanced product portfolio and solidify its position as a leader in the diketene derivatives market. With innovation and expansion at the forefront, the company is poised to capitalise on evolving market trends and deliver value to its customers worldwide.

Yup, I would agree to disagree. Redtape is the most efficient and fastest grower of the lot, We shouldn’t forget with growth comes earnings which ultimately improves valuations. I am expecting the upcoming qtr to be the best one so far, 950-1100 isn’t too distant.

ROCE
Redtape – 44.8%
Relaxo – 11.8%
Bata – 19.6%
Campus – 23%
Metro Brands – 24.3%

Sales QoQ | YoY
Redtape – +90% | +29%
Relaxo – (-) | +4.6%
Bata – +10% | +0.33%
Campus – +82% | +1%
Metro Brands – +14.3% | +6%

PE ratio
Redtape – 58
Relaxo – 102
Bata – 61
Campus – 89.5
Metro brands – 87

What’s fascinating here is the realization of valuation disparity by the market, It is evident how the competition is seeing a fall in premium valuations and how Redtape is being taken to there.

The board has approved the issue of 12,10,000 convertible warrants on preferential basis to Promoter Group at Rs.530/Share. So, infusion of Rs. 64.13 Crs for Approx. 2.8% of total shares. Interesting.

Thanks for information. I will make changes to portfolio accordingly